Physician
OIG excluded
Arassi, Siamak
Arassi, Siamak was paid $796K by Medicaid between Jan 2018 and Jul 2022, across 14 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 31% of everything it billed.
33Billing provider infoARASSI, SIAMAK
BROOKFIELD, WI 53045
BROOKFIELD, WI 53045
33aNPI1083680417assigned 02/26/2006
33bProvider typeAddiction Medicine (Internal Medicine) Physician
28Total paid$796K
24GClaims10,261
24DCodes billed14
24AFirst – last monthJan 2018 – Jul 2022
Compared with peers
Next to other Addiction Medicine (Internal Medicine) Physician providers in Wisconsin
Rank by total paid#3 of 8
Median peer was paid$2K
This provider vs. median448×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
OIG exclusionListed on the federal exclusion list (06/20/2023).
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,072 | $209K | |
| 2019 | 1,218 | $76K | |
| 2020 | 831 | $38K | |
| 2021 | 2,621 | $464K | |
| 2022 | 519 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 31% | 5,193 | 1,394 | $243K |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 28% | 253 | 139 | $225K |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 26% | 219 | 125 | $207K |
| 99354 | 6.8% | 688 | 395 | $54K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 732 | 457 | $18K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 676 | 429 | $17K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.9% | 1,345 | 281 | $15K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 372 | 122 | $7K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 301 | 174 | $6K |
| 80305 | <1% | 218 | 121 | $3K | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 20 | 17 | $349.86 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 217 | 182 | $271.42 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.